Partial Lipodystrophy
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With PL (NCT05164341) | Chiesi Farmaceutici S.p.A. | 2021-12-17 |
| MEASuRE: Metreleptin Effectiveness And Safety Registry (NCT02325674) | Chiesi Farmaceutici S.p.A. | 2016-10-11 |
| Trial of Leptin Replacement Therapy in Patients With Lipodystrophy (NCT00896298) | University of Texas Southwestern Medical Center | 2006-04-01 |
Track Partial Lipodystrophy automatically
Every clearance here is in the API, with alerts when new ones post.